TCM
AGIO icon

Tradewinds Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Tradewinds Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50
Closed -$5K – 662
2015
Q1 		$5K Sell
50
-50
-50% -$5.6K ﹤0.01% 438
2014
Q4 		$11K Buy
+100
New +$8.93K 0.01% 367

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Tradewinds Capital Management's AGIO Position: Q2 2015 in Review

Tradewinds Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2015, closing a stake of 50 shares — an estimated $5K sold.

Tradewinds Capital Management first reported a position in AGIO in Q4 2014 and held it in 2 quarters. The position peaked at $11K in Q4 2014. 161 funds tracked by Wall St. Rank hold AGIO as of Q2 2015.

  • Tradewinds Capital Management reported no remaining Agios Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Tradewinds Capital Management sold 50 Agios Pharmaceuticals shares in Q2 2015, an estimated $5K.
  • Tradewinds Capital Management first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Tradewinds Capital Management's Agios Pharmaceuticals position peaked at $11K in Q4 2014.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2015.

Based on Tradewinds Capital Management's 13F filing for Q2 2015, filed 30 Jul 2015.